t 0O/PWFNCFSUIF.VUVBM+PJOU7JTJU .+7*OTQFDUJPOCZ UIF 0&$% UFBN PG JOTQFDUPST DPNNFODFE 5IFZ XFSF MFE CZ %S
"OESFX (SBZ .FEJDJOFT )FBMUIDBSF QSPEVDUT 3FHVMBUPSZ "HFODZ 6OJUFE,JOHEPNXJUIUXPPUIFSJOTQFDUPSTOBNFMZ%S$ISJTUPQI.PPS 'FEFSBM 0GGJDF GPS UIF &OWJSPONFOU 4XJU[FSMBOE BOE %S )JUPTIJ 4PNFZB UIF 1IBSNBDFVUJDBM .FEJDBM %FWJDF 3FHVMBUPSZ "HFODZ +BQBOBOE.T8BLBLP)PSJLJBOPCTFSWFSGSPN&OWJSPONFOU)FBMUI BOE4BGFUZ%JWJTJPO&OWJSPONFOU%JSFDUPSBUF0&$%1BSJT
t #BTFEPOBMMUIFJOJUJBUJWFTXIJDIIBWFCFFODBSSJFEPVUJOTVQQPSUPGUIF
$."T#JPUFDI$PSQSFNBJOTPQUJNJTUJDBMMZIPQFGVMUIBU.BMBZTJBXJMMBDIJFWF JUTBJNUPCFDPNFBGVMMBEIFSFOUUPUIF0&$%."%TZTUFNJO
Issue / Activity Results
Next Steps for Policy and Regulatory Engagement:
"T UIF .BMBZTJBO CJPUFDIOPMPHZ JOEVTUSZ NPWFT JOUP UIF OFYU QIBTF PG i$PNNFSDJBMJTJOH 4DJFODFUP#VTJOFTTwCFMPXBSFTPNFBSFBTUIBUOFFEUPCFBEESFTTFE
Biosafety and Access and Benefit Sharing (ABS)
t #JPUFDI$PSQTIBMMDPOUJOVFPVSIFBMUIZFOHBHFNFOUXJUIUIF#JPTBGFUZ%FQBSUNFOUPG UIF.JOJTUSZPG/BUVSBM3FTPVSDFTBOE&OWJSPONFOU .P/3&JOUIFBSFBPGCJPTBGFUZ8F XJMMBMTPQBSUJDJQBUFJOUIFDPOTVMUBUJWFQSPDFTTUPXBSETUIFQSPNVMHBUJPOPGUIF"#4MBX BOEXJMMFOHBHFXJUI.P/3&UPQSPWJEFBXBSFOFTTUPUIFJOEVTUSZPOUIFBOUJDJQBUFE EPNFTUJD "#4 MBX .P/3&T DPOTVMUBUJPO XJUI TUBLFIPMEFST PO UIF ESBGU "#4 MBX JT FYQFDUFEUPCFDBSSJFEPVUJO
Intellectual Property
t *UJTFOWJTBHFEUIBUUIFSFXJMMCFBOJODSFBTFJOUIFOVNCFSPG*1TSFHJTUFSFEJOUIFDPVOUSZ BOEXFXJMMDPOUJOVFUPQSPWJEFBXBSFOFTTBOEBEWJDFUPUIFJOEVTUSZPOTUSBUFHJD*1 NBOBHFNFOU .PWJOH GPSXBSE GPDVT TIBMM CF HJWFO UP BSFBT TVDI BT WBMVBUJPO BOE DPMMBUFSBMJTBUJPOPG*1
Pharma Regulations
t #JPUFDI$PSQ XJMM DPOUJOVF UP DPOUSJCVUF JUT JOQVU UP UIF EFWFMPQNFOU PG QIBSNBDFVUJDBM SFHVMBUJPOTJODMVEJOHIBSNPOJTBUJPOPGSFHVMBUPSZGSBNFXPSLGPS"4&"/SFHJPO.PSFPWFS MFWFSBHJOH VQPO PVS TUSPOH SFMBUJPOTIJQ XJUI SFHVMBUPSZ TUBLFIPMEFST XF XJMM QSPWJEF DPOUJOVPVTBOEDPOTUSVDUJWFJOEVTUSZQFSTQFDUJWFJOQVUUPESJWFIFBMUIDBSFCJPUFDIOPMPHZ EFWFMPQNFOU
t 0O/PWFNCFSUIF.VUVBM+PJOU7JTJU .+7*OTQFDUJPOCZ UIF 0&$% UFBN PG JOTQFDUPST DPNNFODFE 5IFZ XFSF MFE CZ %S
"OESFX (SBZ .FEJDJOFT )FBMUIDBSF QSPEVDUT 3FHVMBUPSZ "HFODZ 6OJUFE,JOHEPNXJUIUXPPUIFSJOTQFDUPSTOBNFMZ%S$ISJTUPQI.PPS 'FEFSBM 0GGJDF GPS UIF &OWJSPONFOU 4XJU[FSMBOE BOE %S )JUPTIJ 4PNFZB UIF 1IBSNBDFVUJDBM .FEJDBM %FWJDF 3FHVMBUPSZ "HFODZ +BQBOBOE.T8BLBLP)PSJLJBOPCTFSWFSGSPN&OWJSPONFOU)FBMUI BOE4BGFUZ%JWJTJPO&OWJSPONFOU%JSFDUPSBUF0&$%1BSJT
t #BTFEPOBMMUIFJOJUJBUJWFTXIJDIIBWFCFFODBSSJFEPVUJOTVQQPSUPGUIF
$."T#JPUFDI$PSQSFNBJOTPQUJNJTUJDBMMZIPQFGVMUIBU.BMBZTJBXJMMBDIJFWF JUTBJNUPCFDPNFBGVMMBEIFSFOUUPUIF0&$%."%TZTUFNJO
Issue / Activity Results
Next Steps for Policy and Regulatory Engagement:
"T UIF .BMBZTJBO CJPUFDIOPMPHZ JOEVTUSZ NPWFT JOUP UIF OFYU QIBTF PG i$PNNFSDJBMJTJOH 4DJFODFUP#VTJOFTTwCFMPXBSFTPNFBSFBTUIBUOFFEUPCFBEESFTTFE
Biosafety and Access and Benefit Sharing (ABS)
t #JPUFDI$PSQTIBMMDPOUJOVFPVSIFBMUIZFOHBHFNFOUXJUIUIF#JPTBGFUZ%FQBSUNFOUPG UIF.JOJTUSZPG/BUVSBM3FTPVSDFTBOE&OWJSPONFOU .P/3&JOUIFBSFBPGCJPTBGFUZ8F XJMMBMTPQBSUJDJQBUFJOUIFDPOTVMUBUJWFQSPDFTTUPXBSETUIFQSPNVMHBUJPOPGUIF"#4MBX BOEXJMMFOHBHFXJUI.P/3&UPQSPWJEFBXBSFOFTTUPUIFJOEVTUSZPOUIFBOUJDJQBUFE EPNFTUJD "#4 MBX .P/3&T DPOTVMUBUJPO XJUI TUBLFIPMEFST PO UIF ESBGU "#4 MBX JT FYQFDUFEUPCFDBSSJFEPVUJO
Intellectual Property
t *UJTFOWJTBHFEUIBUUIFSFXJMMCFBOJODSFBTFJOUIFOVNCFSPG*1TSFHJTUFSFEJOUIFDPVOUSZ BOEXFXJMMDPOUJOVFUPQSPWJEFBXBSFOFTTBOEBEWJDFUPUIFJOEVTUSZPOTUSBUFHJD*1 NBOBHFNFOU .PWJOH GPSXBSE GPDVT TIBMM CF HJWFO UP BSFBT TVDI BT WBMVBUJPO BOE DPMMBUFSBMJTBUJPOPG*1
Pharma Regulations
t #JPUFDI$PSQ XJMM DPOUJOVF UP DPOUSJCVUF JUT JOQVU UP UIF EFWFMPQNFOU PG QIBSNBDFVUJDBM SFHVMBUJPOTJODMVEJOHIBSNPOJTBUJPOPGSFHVMBUPSZGSBNFXPSLGPS"4&"/SFHJPO.PSFPWFS MFWFSBHJOH VQPO PVS TUSPOH SFMBUJPOTIJQ XJUI SFHVMBUPSZ TUBLFIPMEFST XF XJMM QSPWJEF DPOUJOVPVTBOEDPOTUSVDUJWFJOEVTUSZQFSTQFDUJWFJOQVUUPESJWFIFBMUIDBSFCJPUFDIOPMPHZ EFWFMPQNFOU
BUSINESS INTELLIGENCE
5JNFMZ BWBJMBCJMJUZ PG LFZ CVTJOFTT JOGPSNBUJPO BOE LOPXMFEHF JT DSJUJDBM GPS CVTJOFTTFT UP NBJOUBJOBMFBEJOHQBDFJOUPEBZTDPNQFUJUJWFNBSLFUQMBDF3FDPHOJTJOHUIJTOFFEBOFX EFQBSUNFOU DBMMFE #VTJOFTT *OUFMMJHFODF #* XBT FTUBCMJTIFE JO VOEFS UIF 4USBUFHJD 1MBOOJOH%JWJTJPO
Focus Areas:
1SPWJEJOHBDDVSBUFBOEUJNFMZNBSLFUBOEJOEVTUSZJOUFMMJHFODFUP#JPUFDI$PSQTJOUFSOBM TUBLFIPMEFST GPS CFUUFS TUSBUFHZ EFWFMPQNFOU GBTUFS EFDJTJPO NBLJOH UBSHFUFE HPWFSONFOUJOEVTUSZFOHBHFNFOUBOEJNQBDUGVMJOUFSWFOUJPOBMJOJUJBUJWFTJNQMFNFOUBUJPO 5PCFBPOFTUPQDFOUFSGPSJOGPSNBUJPOPOCJPUFDIOPMPHZJOEVTUSZGPSCPUIJOUFSOBMBOE
FYUFSOBMTUBLFIPMEFSTBOEUPGBDJMJUBUFOFUXPSLJOHDPMMBCPSBUJPOCFUXFFOUIFTFQBSUJFT
1SPWJEJOHNBSLFUBOE JOEVTUSZJOUFMMJHFODFUP
JOUFSOBMTUBLFIPMEFST
*OUFSOBUJPOBM
"DDSFEJUBUJPO (-1
#*QVCMJTIFE2VBSUFSMZ#JPUFDIOPMPHZ*OEVTUSZ3FQPSUTBOE"OBMZTJTGPS FBDIJOEVTUSZTFDUPSXJUIBUPUBMPGGPVSRVBSUFSMZSFQPSUTCFJOHQVCMJTIFE JOBTGPMMPXT
t 3FBMJTFE JOWFTUNFOU BOE SFWFOVF HFOFSBUJPO HBQT XJUIJO
#JPUFDI$PSQT"QQSPWFE#VTJOFTT1MBOBTDPNQBSFEBHBJOTUUIF /BUJPOBM#JPUFDIOPMPHZ1PMJDZ /#11IBTF**UBSHFUT
t 1PTJUJPOJOH.BMBZTJBJOBUUSBDUJOHHMPCBMCJPUFDIOPMPHZ'PSFJHO%JSFDU
*OWFTUNFOU '%*
t .BSLFUBDDFTTGPS.BMBZTJBOCJPUFDIOPMPHZDPNQBOJFTBOE
t *OUFSOBUJPOBMMJOLBHFTBOETQFDJGJDGPSFJHODPNQBOJFTXJUITJHOJGJDBOU CVTJOFTT PQQPSUVOJUJFT GPS #VTJOFTT %FWFMPQNFOU BOE *OWFTUNFOU #%*UFBNUPBQQSPBDIGPSQPUFOUJBM'%*BOEDPMMBCPSBUJPOT
"UPUBMPG4FOJPS.BOBHFNFOU"MFSUTXFSFJTTVFEJOJODMVEJOH JOGPSNBUJPOPO.BMBZTJBTHSPTTEPNFTUJDQSPEVDU (%1HSPXUITIJGUT JO .BMBZTJBO VUJMJUZ UBSJGGT UIBU DPVME JNQBDU JOWFTUNFOU QPUFOUJBM QMBUGPSNUFDIOPMPHJFTBOEUIFJSQSPTQFDUJWFPQQPSUVOJUJFTQPUFOUJBM'%*
DMJFOUTBOEDPMMBCPSBUJPOPQQPSUVOJUJFTXJUIGPSFJHOQBSUOFSTBTXFMMBT TJHOJGJDBOUEFWFMPQNFOUTXJUIJOUIFCJPUFDIOPMPHZJOEVTUSZXJUITUSPOH SFMFWBODF UP .BMBZTJB5IF BMFSUT BSF B NFDIBOJTN EFWFMPQFE UP BMFSU UIF 4FOJPS .BOBHFNFOU BCPVU JNQPSUBOU EFWFMPQNFOUT XJUIJO UIF CJPUFDIOPMPHZJOEVTUSZJOBUJNFMZNBOOFS
Activity Results
tProposed collaboration with Insect Biotech Co. Ltd for Human Capital Internship Programme;
tImplementation Council Meeting Funding Proposal; and tProposed Malaysia and Italy Collaboration in Biotechnology.
One-stop-center for information and facilitate networking/collaboration
between all stakeholders
Smart partnerships In line with Malaysia entering into Phase 2 of the National Biotechnology Policy entailing commercialisation, there is an immediate need for the BiotechCorp Resource Centre to expand and collaborate with relevant organisations/libraries for information sharing to assist in successful implementation. Acknowledging the importance of close collaborations and information sharing, BI had actively engaged and initiated several smart partnerships in the year 2011 with several important business intelligence/knowledge centers in the country, notably Petronas Research Center, and Knowledge Center@Bursa, Bursa Malaysia. The collaborations primarily aim to fulfill the educational, intellectual, informational and social aspirations of users, through cooperative provision, superior quality library resources and services made available to the users.
Activity Results
Industry updates and market developments
to external stakeholders through
published materials
In 2011, BI has achieved the stretched target with the publication of three articles in regionally and globally significant periodicals, as follows:
tMalaysia as a destination for foreign biotechnology investments (Asia Pacific Biotech News, September 2011);
tAustralia-Malaysia: Forging ahead (Roxy Media, November 2011); and tBiotech investments to target Malaysia, says BiotechCorp (Malaysian
Reserve, November 2011).
BI also publishes the BioMonthly, a monthly publication prepared with the intention to provide stakeholders with information on BioNexus Status companies, economy and financial outlook, and selected developments on focus areas in Agriculture, Healthcare and Industrial Biotechnology in Malaysia, as well as other parts of the world. A total of twelve BioMonthly issues have been published in 2011.
BI maintained a weekly news update called BioNews, with 52 issues released for the year 2011, in order to keep stakeholders up-to-date with the latest on-goings in the biotechnology industry.
Creating a platform for engagement in the
promotion of the Bioeconomy Initiative
Malaysia (BIM)
BI has been directly involved since the inception of this master plan, and has been instrumental at facilitating the groundwork for the BIM.
BIM is the framework for the nation to develop a high-income bioeconomy through a sustainable ecosystem of research and development (R&D) and commercialisation in the areas of agriculture, healthcare and industrial biotechnology by 2020.
One of the key highlights of this drive was the launch of the BIM at BioMalaysia 2011 by the Prime Minister of Malaysia Yang Amat Berhormat Dato’ Seri Najib Tun Razak. Moving forward, BI will continue with its contribution and involvement in the BIM, in particular the BIM workshop and lab in March 2012, which will be held collaboratively with the Ministry of Science, Technology and Innovation (MOSTI).
One-stop-center for information and facilitate networking/collaboration
between all stakeholders
Provided content for presentation to Cluster Working Groups/Senior Management, where a total of six contents items were provided as follows:
tProposed Collaboration with Chungbuk Bio Valley Development Bureau;
tProposed collaboration with Chungcheong Leading Industry Office in Korea for Human Capital Internship Programme;
tProposed collaboration with Korean Biotechnology Industry
Activity Results
Next Steps for Business Intelligence:
As part of efforts to ensure that BiotechCorp remains relevant to its stakeholders moving forward, Business Intelligence will be undertaking the following activities:
tIn 2012, Business Intelligence will be renamed Corporate Innovation Strategy to further reflect the work to be undertaken in the ensuing years; and
t $POUJOVPVTGPDVTXJMMCFQMBDFEJODIBSUJOHUIFEJSFDUJPOPGCJPUFDIOPMPHZJOEVTUSZUPFODPVSBHF innovation and assist commercialisation of local biotechnology industry through coordination and collaboration with relevant agencies.
tProposed collaboration with Insect Biotech Co. Ltd for Human Capital Internship Programme;
tImplementation Council Meeting Funding Proposal; and tProposed Malaysia and Italy Collaboration in Biotechnology.
One-stop-center for information and facilitate networking/collaboration
between all stakeholders
Smart partnerships In line with Malaysia entering into Phase 2 of the National Biotechnology Policy entailing commercialisation, there is an immediate need for the BiotechCorp Resource Centre to expand and collaborate with relevant organisations/libraries for information sharing to assist in successful implementation. Acknowledging the importance of close collaborations and information sharing, BI had actively engaged and initiated several smart partnerships in the year 2011 with several important business intelligence/knowledge centers in the country, notably Petronas Research Center, and Knowledge Center@Bursa, Bursa Malaysia. The collaborations primarily aim to fulfill the educational, intellectual, informational and social aspirations of users, through cooperative provision, superior quality library resources and services made available to the users.
Activity Results
Industry updates and market developments
to external stakeholders through
published materials
In 2011, BI has achieved the stretched target with the publication of three articles in regionally and globally significant periodicals, as follows:
tMalaysia as a destination for foreign biotechnology investments (Asia Pacific Biotech News, September 2011);
tAustralia-Malaysia: Forging ahead (Roxy Media, November 2011); and tBiotech investments to target Malaysia, says BiotechCorp (Malaysian
Reserve, November 2011).
BI also publishes the BioMonthly, a monthly publication prepared with the intention to provide stakeholders with information on BioNexus Status companies, economy and financial outlook, and selected developments on focus areas in Agriculture, Healthcare and Industrial Biotechnology in Malaysia, as well as other parts of the world. A total of twelve BioMonthly issues have been published in 2011.
BI maintained a weekly news update called BioNews, with 52 issues released for the year 2011, in order to keep stakeholders up-to-date with the latest on-goings in the biotechnology industry.
Creating a platform for engagement in the
promotion of the Bioeconomy Initiative
Malaysia (BIM)
BI has been directly involved since the inception of this master plan, and has been instrumental at facilitating the groundwork for the BIM.
BIM is the framework for the nation to develop a high-income bioeconomy through a sustainable ecosystem of research and development (R&D) and commercialisation in the areas of agriculture, healthcare and industrial biotechnology by 2020.
One of the key highlights of this drive was the launch of the BIM at BioMalaysia 2011 by the Prime Minister of Malaysia Yang Amat Berhormat Dato’ Seri Najib Tun Razak. Moving forward, BI will continue with its contribution and involvement in the BIM, in particular the BIM workshop and lab in March 2012, which will be held collaboratively with the Ministry of Science, Technology and Innovation (MOSTI).
One-stop-center for information and facilitate networking/collaboration
between all stakeholders
Provided content for presentation to Cluster Working Groups/Senior Management, where a total of six contents items were provided as follows:
tProposed Collaboration with Chungbuk Bio Valley Development Bureau;
tProposed collaboration with Chungcheong Leading Industry Office in Korea for Human Capital Internship Programme;
tProposed collaboration with Korean Biotechnology Industry
Activity Results
Next Steps for Business Intelligence:
As part of efforts to ensure that BiotechCorp remains relevant to its stakeholders moving forward, Business Intelligence will be undertaking the following activities:
tIn 2012, Business Intelligence will be renamed Corporate Innovation Strategy to further reflect the work to be undertaken in the ensuing years; and
t $POUJOVPVTGPDVTXJMMCFQMBDFEJODIBSUJOHUIFEJSFDUJPOPGCJPUFDIOPMPHZJOEVTUSZUPFODPVSBHF innovation and assist commercialisation of local biotechnology industry through coordination and collaboration with relevant agencies.